Fortitude Invests $1M in HeartSciences at 22% Premium, Merger Terms Unchanged
HSCS sits 37% above its 52-week low of $1.63.
Summary
Fortitude Mining Holdings is investing $1.0 million in HeartSciences at a 22% premium to the current market price, with no adjustment to the merger consideration. This direct cash infusion from the merger partner signals confidence in the deal and provides near-term liquidity. Following the investment, Fortitude now holds about 9.4% of HeartSciences' outstanding shares of common stock. The premium price suggests Fortitude values HeartSciences above its current trading level, which could support the stock. The investment follows the definitive all-stock merger agreement announced in June and the recent 10-K that raised going concern warnings. The merger proxy is pending, and this investment may help address liquidity concerns ahead of the shareholder vote.
At the time of this announcement, HSCS was trading at $2.23 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $8.3M. The 52-week trading range was $1.63 to $3.93. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.